Day: March 21, 2020

Sarilumab enters clinical trial for COVID-19, spotlighting ‘key role’ for IL-6

Source: Healio By Cassandra Calabrese The rheumatoid arthritis drug sarilumab is set to enter a clinical trial program for patients hospitalized with severe COVID-19 infection, according to a joint statement released by Regeneron Pharmaceuticals and Sanofi. Sarilumab (Kevzara) — jointly developed Regeneron and Sanofi — is a fully human, monoclonal […]